...and when those large chunk placements at a discount to the trading price are done, retail price typically adjusts down to that price as that is what large investors (presumably savvy) and the CEO have decided the stock price is worth. Why would retail pay more than that price plus say 20%? KW and his investors think the stock is worth no more than $0.006
When a company does a raise of money they don't offer it at a discount of 80% to current price. Unless that is a desperate attempt to just stay afloat.
They had an at the market agreement but KW's incompetence has tanked the market cap taking that offer off the table so now they are stuck selling at huge above average discounts.
they do a placement at a discount to the trading price its a normal everyday practice in the stock market. Anyone that tries to tell you different is either lying to you or just doesn't know how money is raised in the stock market
Well, in that case let's consider your example:
Cocrystal Pharma Files For $150 Million Mixed Shelf Offering
Which has the purpose of registering the stock. It has nothing to do with how the stock is subsequently sold. And what is the history of your example, and how it sells its stock??? Oh looky looky at a couple of recent headlines:
Cocrystal Pharma Announces Closing of $6.8 Million Registered Direct Offering Priced At-the-Market
Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market
Priced At-the-Market means exactly that. The going Market price. As in NO discount.
No, it's not "normal everyday practice" for a stock to offer up 500% discounts to the going Market price of a stock And in your own words... "Anyone that tries to tell you different is either lying to you or just doesn't know how money is raised in the stock market". Including what an S-3 is used for. Yes PMCB offered up its stock at a 500% discount at 0.0041 relative to a "At-The-Market" price of 0.02. That seems to be "normal" for PMCB. It's also normal for Microcrap scams in general.
$PMCB PharmaCyte Biotech: Smells Like A Pump And Dump
With limited R&D spend, only 4 employees, persistent dilution to shareholder, consistent use of paid promotion and $100 million in accumulated losses. ALSO this CEO is hiding his entity that he is associate with 2 scam companies before.